CS Pharmaceuticals Limited

CS Pharmaceuticals (CSP) is a London-headquartered specialty pharmaceutical company with a strategic focus on the development and commercialization of innovative ophthalmology and rare disease products in China. The company acts as a bridge between Western pharmaceutical companies and the Chinese market, taking responsibility for clinical, regulatory, and commercialization activities to address high unmet medical needs. CSP leverages its expertise in the Chinese regulatory and healthcare landscape to license, develop, and commercialize unique, under-the-radar products. The company maintains a significant operational presence in Beijing and Shanghai, allowing it to navigate the complexities of the Chinese market while adhering to Western compliance and quality standards.